{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:16:27Z","timestamp":1791231387354,"version":"4.1.0"},"reference-count":172,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FOC"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:p>Glioblastoma multiforme (GBM) is a devastating malignant brain tumor characterized by resistance to available therapeutic approaches and relentless malignant progression that includes widespread intracranial invasion, destruction of normal brain tissue, progressive disability, and death. Stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (fSRT) are increasingly used in patients with recurrent GBM to complement traditional treatments such as resection, conventional external beam radiotherapy, and chemotherapy. Both SRS and fSRT are powerful noninvasive therapeutic modalities well suited to treat focal neoplastic lesions through the delivery of precise, highdose radiation. Although no randomized clinical trials have been performed, a variety of retrospective studies have been focused on the use of SRS and fSRT for recurrent GBMs. In addition, state-of-the-art neuroimaging techniques, such as MR spectroscopic imaging, diffusion tensor tractography, and nuclear medicine imaging, have enhanced treatment planning methods leading to potentially improved clinical outcomes. In this paper the authors reviewed the current applications and efficacy of SRS and fSRT in the treatment of GBM, highlighting the value of these therapies for recurrent focal disease.<\/jats:p>","DOI":"10.3171\/2009.9.focus09187","type":"journal-article","created":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T10:04:21Z","timestamp":1259661861000},"page":"E8","source":"Crossref","is-referenced-by-count":63,"title":["Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme"],"prefix":"10.3171","volume":"27","author":[{"given":"Pantaleo","family":"Romanelli","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Istituto di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Conti","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pontoriero","sequence":"additional","affiliation":[{"name":"Radiation Oncology, University of Messina; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Kenneth","family":"Ricciardi","sequence":"additional","affiliation":[{"name":"Department of Neuro-radiology, University of Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tomasello","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"De Renzis","sequence":"additional","affiliation":[{"name":"Radiation Oncology, University of Messina; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gualtiero","family":"Innocenzi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Istituto di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Istituto di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Cantore","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Istituto di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-0270008","series-title":"Br J Neurosurg","first-page":"452","article-title":"\u2018Recurrent' glioblastoma multiforme, when should we reoperate?","volume":"22","author":"Barbagallo","year":"2008"},{"key":"b2-0270008","series-title":"Neurosurgery","first-page":"709","article-title":"Survival and functional status after resection of recurrent glioblastoma multiforme","volume":"42","author":"Barker","year":"1998"},{"key":"b3-0270008","series-title":"J Neurosurg","first-page":"1","article-title":"Stereotactic radiosurgery\u2014an organized neurosurgery-sanctioned definition","volume":"106","author":"Barnett","year":"2007"},{"key":"b4-0270008","series-title":"J Neurooncol","first-page":"191","article-title":"Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme","volume":"67","author":"Baumann","year":"2004"},{"key":"b5-0270008","series-title":"Neurosurgery","first-page":"371","article-title":"Interstitial brachytherapy for malignant brain tumors: preliminary results","volume":"26","author":"Bernstein","year":"1990"},{"key":"b6-0270008","series-title":"Br J Cancer","first-page":"769","article-title":"A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma","volume":"64","author":"Bleehen","year":"1991"},{"issue":"3B","key":"b7-0270008","series-title":"Anticancer Res","first-page":"1913","article-title":"New drugs in recurrent high grade gliomas","volume":"20","author":"Brandes","year":"2000"},{"key":"b8-0270008","series-title":"Lancet","first-page":"1008","article-title":"Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas","volume":"345","author":"Brem","year":"1995"},{"key":"b9-0270008","series-title":"Clin Cancer Res","first-page":"4738","article-title":"Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms","volume":"12","author":"Chakravarti","year":"2006"},{"key":"b10-0270008","series-title":"Cancer","first-page":"1213","article-title":"Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme","volume":"100","author":"Chamberlain","year":"2004"},{"key":"b11-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1133","article-title":"Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy","volume":"62","author":"Chan","year":"2005"},{"key":"b12-0270008","series-title":"Med Dosim","first-page":"42","article-title":"Feasibility study of intensity-modulated radiotherapy (IMRT) treatment planning using brain functional MRI","volume":"33","author":"Chang","year":"2008"},{"key":"b13-0270008","series-title":"Med Phys","first-page":"32","article-title":"Image-fusion of MR spectroscopic images for treatment planning of gliomas","volume":"33","author":"Chang","year":"2006"},{"key":"b14-0270008","series-title":"Clin Adv Hematol Oncol","first-page":"894","article-title":"Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme","volume":"5","author":"Chang","year":"2007"},{"key":"b15-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1133","article-title":"Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas","volume":"45","author":"Cho","year":"1999"},{"key":"b16-0270008","series-title":"Neurooncol","first-page":"38","article-title":"Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme","volume":"6","author":"Chua","year":"2004"},{"key":"b17-0270008","series-title":"J Clin Oncol","first-page":"3651","article-title":"Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study","volume":"24","author":"Cloughesy","year":"2006"},{"key":"b18-0270008","series-title":"J Neurooncol","first-page":"205","article-title":"Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas","volume":"89","author":"Combs","year":"2008"},{"key":"b19-0270008","series-title":"Strahlenther Onkol","first-page":"372","article-title":"Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I\/II study","volume":"181","author":"Combs","year":"2005"},{"key":"b20-0270008","series-title":"Radiother Oncol","first-page":"177","article-title":"Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors","volume":"88","author":"Combs","year":"2008"},{"key":"b21-0270008","series-title":"J Clin Oncol","first-page":"8863","article-title":"Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution","volume":"23","author":"Combs","year":"2005"},{"key":"b22-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"999","article-title":"Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens","volume":"71","author":"Combs","year":"2008"},{"key":"b23-0270008","series-title":"Cancer","first-page":"2168","article-title":"Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM)","volume":"104","author":"Combs","year":"2005"},{"issue":"4","key":"b24-0270008","series-title":"Neurosurg Focus","first-page":"E17","article-title":"Gamma knife surgery for glioblastoma multiforme","volume":"20","author":"Crowley","year":"2006"},{"key":"b25-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1515","article-title":"Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas","volume":"60","author":"DiBiase","year":"2004"},{"key":"b26-0270008","series-title":"Radiology","first-page":"823","article-title":"Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy","volume":"166","author":"Earnest","year":"1988"},{"key":"b27-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"879","article-title":"An integrated logistic formula for prediction of complications from radiosurgery","volume":"17","author":"Flickinger","year":"1989"},{"key":"b28-0270008","series-title":"J Clin Oncol","first-page":"5294","article-title":"Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study","volume":"23","author":"Galanis","year":"2005"},{"key":"b29-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"977","article-title":"Permanent 125iodine implants for recurrent malignant gliomas","volume":"43","author":"Gaspar","year":"1999"},{"key":"b30-0270008","series-title":"J Clin Oncol","first-page":"1642","article-title":"Stereotactic radiosurgery for recurrent malignant gliomas","volume":"13","author":"Hall","year":"1995"},{"key":"b31-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"541","article-title":"Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas","volume":"35","author":"Halligan","year":"1996"},{"key":"b32-0270008","series-title":"Neurology","first-page":"907","article-title":"Assumptions in the radiotherapy of glioblastoma","volume":"30","author":"Hochberg","year":"1980"},{"key":"b33-0270008","series-title":"Neurosurgery","first-page":"684","article-title":"Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme","volume":"57","author":"Hsieh","year":"2005"},{"key":"b34-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"293","article-title":"A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma","volume":"43","author":"Hudes","year":"1999"},{"key":"b35-0270008","series-title":"Clin Oncol (R Coll Radiol)","first-page":"581","article-title":"Diffusion tensor imaging: possible implications for radiotherapy treatment planning of patients with high-grade glioma","volume":"17","author":"Jena","year":"2005"},{"key":"b36-0270008","series-title":"Neurosurgery","first-page":"776","article-title":"Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms","volume":"41","author":"Kondziolka","year":"1997"},{"key":"b37-0270008","series-title":"J Neurosurg","first-page":"44","article-title":"Long-term outcomes after meningioma radiosurgery: physician and patient perspectives","volume":"91","author":"Kondziolka","year":"1999"},{"key":"b38-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1553","article-title":"Evidence that MR diffusion tensor imaging (tractography) predicts the natural history of regional progression in patients irradiated conformally for primary brain tumors","volume":"71","author":"Krishnan","year":"2008"},{"key":"b39-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1005","article-title":"Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma","volume":"41","author":"Laperriere","year":"1998"},{"key":"b40-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1045","article-title":"Gamma knife for glioma: selection factors and survival","volume":"36","author":"Larson","year":"1996"},{"key":"b41-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1397","article-title":"Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma","volume":"54","author":"Larson","year":"2002"},{"key":"b42-0270008","series-title":"Neuro-oncol","first-page":"119","article-title":"Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme","volume":"6","author":"Larson","year":"2004"},{"key":"b43-0270008","series-title":"Stereotact Funct Neurosurg","first-page":"162","article-title":"Recurrent glioblastoma multiforme: potential benefits using fractionated stereotactic radiotherapy and concurrent taxol","volume":"69","author":"Lederman","year":"1997"},{"key":"b44-0270008","series-title":"Am J Clin Oncol","first-page":"155","article-title":"Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel","volume":"23","author":"Lederman","year":"2000"},{"key":"b45-0270008","series-title":"Med Phys","first-page":"1563","article-title":"Functional magnetic resonance imaging aided radiation treatment planning","volume":"27","author":"Liu","year":"2000"},{"key":"b46-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1113","article-title":"The effect of setup uncertainties on the radiobiological advantage of fractionation in stereotaxic radiotherapy","volume":"34","author":"Lo","year":"1996"},{"key":"b47-0270008","series-title":"J Neurosurg","first-page":"210","article-title":"Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme","volume":"103","author":"Mahajan","year":"2005"},{"key":"b48-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"243","article-title":"Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume","volume":"7","author":"Marks","year":"1981"},{"key":"b49-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1350","article-title":"Reirradiation tolerance of the human brain","volume":"70","author":"Mayer","year":"2008"},{"key":"b50-0270008","series-title":"J Clin Oncol","first-page":"2529","article-title":"Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases","volume":"21","author":"Mehta","year":"2003"},{"key":"b51-0270008","series-title":"J Clin Oncol","first-page":"2563","article-title":"Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981\/22981-NCIC CE3 phase III randomized trial","volume":"24","author":"Mirimanoff","year":"2006"},{"key":"b52-0270008","series-title":"Br J Radiol","first-page":"347","article-title":"Use of MR spectroscopy and functional imaging in the treatment planning of gliomas","volume":"80","author":"Narayana","year":"2007"},{"key":"b53-0270008","series-title":"J Neurooncol","first-page":"185","article-title":"Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival","volume":"92","author":"Patel","year":"2009"},{"key":"b54-0270008","series-title":"Neurosurgery","first-page":"1123","article-title":"Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme","volume":"46","author":"Patel","year":"2000"},{"key":"b55-0270008","series-title":"J Neurooncol","first-page":"409","article-title":"Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma","volume":"4","author":"Pouratian","year":"2009"},{"key":"b56-0270008","series-title":"J Clin Oncol","first-page":"579","article-title":"Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma","volume":"27","author":"Prados","year":"2009"},{"key":"b57-0270008","series-title":"Eur J Cancer","first-page":"1809","article-title":"Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy","volume":"30A","author":"Rajan","year":"1994"},{"key":"b58-0270008","series-title":"Neuro-oncol","first-page":"330","article-title":"Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma","volume":"10","author":"Reardon","year":"2008"},{"key":"b59-0270008","series-title":"Technol Cancer Res Treat","first-page":"421","article-title":"Image-guided radiosurgical ablation of intra- and extra-cranial lesions","volume":"5","author":"Romanelli","year":"2006"},{"key":"b60-0270008","series-title":"Comput Aided Surg","first-page":"161","article-title":"Computer aided robotic radiosurgery","volume":"11","author":"Romanelli","year":"2006"},{"key":"b61-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"993","article-title":"A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas","volume":"70","author":"Schwer","year":"2008"},{"key":"b62-0270008","series-title":"Neurosurgery","first-page":"343","article-title":"The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine","volume":"51","author":"Selker","year":"2002"},{"key":"b63-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"291","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000"},{"key":"b64-0270008","series-title":"J Neurosurg","first-page":"972","article-title":"Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation","volume":"108","author":"Sheehan","year":"2008"},{"key":"b65-0270008","series-title":"J Neurosurg","first-page":"226","article-title":"Effect of trans sodium crocetinate on brain tumor oxgenation. Laboratory investigation","volume":"111","author":"Sheehan","year":"2009"},{"key":"b66-0270008","series-title":"J Neurosurg","first-page":"72","article-title":"Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome","volume":"90","author":"Shrieve","year":"1999"},{"key":"b67-0270008","series-title":"Neurosurgery","first-page":"275","article-title":"Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme","volume":"36","author":"Shrieve","year":"1995"},{"key":"b68-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"719","article-title":"Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost","volume":"29","author":"Sneed","year":"1994"},{"key":"b69-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"37","article-title":"Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme","volume":"35","author":"Sneed","year":"1996"},{"key":"b70-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"287","article-title":"Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +\/\u2212 hyperthermia for glioblastoma multiforme","volume":"40","author":"Sneed","year":"1998"},{"key":"b71-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"853","article-title":"Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol","volume":"60","author":"Souhami","year":"2004"},{"key":"b72-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"591","article-title":"Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas: a comparative survival analysis","volume":"30","author":"Stea","year":"1994"},{"key":"b73-0270008","series-title":"J Clin Oncol","first-page":"1375","article-title":"Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide","volume":"20","author":"Stupp","year":"2002"},{"key":"b74-0270008","series-title":"Lancet Oncol","first-page":"552","article-title":"Current and future developments in the use of temozolomide for the treatment of brain tumours","volume":"2","author":"Stupp","year":"2001"},{"key":"b75-0270008","series-title":"Lancet Oncol","first-page":"459","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009"},{"key":"b76-0270008","series-title":"N Engl J Med","first-page":"987","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005"},{"issue":"4 Suppl 13","key":"b77-0270008","series-title":"Semin Oncol","first-page":"19","article-title":"New approaches for temozolomide therapy: use in newly diagnosed glioma","volume":"28","author":"Stupp","year":"2001"},{"key":"b78-0270008","series-title":"Curr Neurol Neurosci Rep","first-page":"198","article-title":"Optimal role of temozolomide in the treatment of malignant gliomas","volume":"5","author":"Stupp","year":"2005"},{"key":"b79-0270008","series-title":"J Neurosurg","first-page":"297","article-title":"An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial","volume":"99","author":"Tatter","year":"2003"},{"key":"b80-0270008","series-title":"Neurosurg Rev","first-page":"417","article-title":"Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience","volume":"32","author":"Villavicencio","year":"2009"},{"key":"b81-0270008","series-title":"BMC Cancer","first-page":"55","article-title":"Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma","volume":"5","author":"Vordermark","year":"2005"},{"key":"b82-0270008","series-title":"Clin Cancer Res","first-page":"1253","article-title":"Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma","volume":"13","author":"Vredenburgh","year":"2007"},{"key":"b83-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1725","article-title":"An analysis of dose-effect relationship in the radiotherapy of malignant gliomas","volume":"5","author":"Walker","year":"1979"},{"key":"b84-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1405","article-title":"Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma","volume":"16","author":"Wallner","year":"1989"},{"key":"b85-0270008","series-title":"Cancer","first-page":"3029","article-title":"Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas","volume":"73","author":"Wen","year":"1994"},{"issue":"4 Suppl","key":"b86-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"S26","article-title":"Hypofractionated stereotactic radiotherapy combined with topotecan in recurrent malignant glioma","volume":"66","author":"Wurm","year":"2006"},{"key":"b1-0270008","series-title":"Br J Neurosurg","first-page":"452","article-title":"\u2018Recurrent' glioblastoma multiforme, when should we reoperate?","volume":"22","author":"Barbagallo","year":"2008"},{"key":"b2-0270008","series-title":"Neurosurgery","first-page":"709","article-title":"Survival and functional status after resection of recurrent glioblastoma multiforme","volume":"42","author":"Barker","year":"1998"},{"key":"b3-0270008","series-title":"J Neurosurg","first-page":"1","article-title":"Stereotactic radiosurgery\u2014an organized neurosurgery-sanctioned definition","volume":"106","author":"Barnett","year":"2007"},{"key":"b4-0270008","series-title":"J Neurooncol","first-page":"191","article-title":"Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme","volume":"67","author":"Baumann","year":"2004"},{"key":"b5-0270008","series-title":"Neurosurgery","first-page":"371","article-title":"Interstitial brachytherapy for malignant brain tumors: preliminary results","volume":"26","author":"Bernstein","year":"1990"},{"key":"b6-0270008","series-title":"Br J Cancer","first-page":"769","article-title":"A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma","volume":"64","author":"Bleehen","year":"1991"},{"issue":"3B","key":"b7-0270008","series-title":"Anticancer Res","first-page":"1913","article-title":"New drugs in recurrent high grade gliomas","volume":"20","author":"Brandes","year":"2000"},{"key":"b8-0270008","series-title":"Lancet","first-page":"1008","article-title":"Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas","volume":"345","author":"Brem","year":"1995"},{"key":"b9-0270008","series-title":"Clin Cancer Res","first-page":"4738","article-title":"Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms","volume":"12","author":"Chakravarti","year":"2006"},{"key":"b10-0270008","series-title":"Cancer","first-page":"1213","article-title":"Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme","volume":"100","author":"Chamberlain","year":"2004"},{"key":"b11-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1133","article-title":"Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy","volume":"62","author":"Chan","year":"2005"},{"key":"b12-0270008","series-title":"Med Dosim","first-page":"42","article-title":"Feasibility study of intensity-modulated radiotherapy (IMRT) treatment planning using brain functional MRI","volume":"33","author":"Chang","year":"2008"},{"key":"b13-0270008","series-title":"Med Phys","first-page":"32","article-title":"Image-fusion of MR spectroscopic images for treatment planning of gliomas","volume":"33","author":"Chang","year":"2006"},{"key":"b14-0270008","series-title":"Clin Adv Hematol Oncol","first-page":"894","article-title":"Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme","volume":"5","author":"Chang","year":"2007"},{"key":"b15-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1133","article-title":"Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas","volume":"45","author":"Cho","year":"1999"},{"key":"b16-0270008","series-title":"Neurooncol","first-page":"38","article-title":"Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme","volume":"6","author":"Chua","year":"2004"},{"key":"b17-0270008","series-title":"J Clin Oncol","first-page":"3651","article-title":"Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study","volume":"24","author":"Cloughesy","year":"2006"},{"key":"b18-0270008","series-title":"J Neurooncol","first-page":"205","article-title":"Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas","volume":"89","author":"Combs","year":"2008"},{"key":"b19-0270008","series-title":"Strahlenther Onkol","first-page":"372","article-title":"Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I\/II study","volume":"181","author":"Combs","year":"2005"},{"key":"b20-0270008","series-title":"Radiother Oncol","first-page":"177","article-title":"Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors","volume":"88","author":"Combs","year":"2008"},{"key":"b21-0270008","series-title":"J Clin Oncol","first-page":"8863","article-title":"Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution","volume":"23","author":"Combs","year":"2005"},{"key":"b22-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"999","article-title":"Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens","volume":"71","author":"Combs","year":"2008"},{"key":"b23-0270008","series-title":"Cancer","first-page":"2168","article-title":"Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM)","volume":"104","author":"Combs","year":"2005"},{"issue":"4","key":"b24-0270008","series-title":"Neurosurg Focus","first-page":"E17","article-title":"Gamma knife surgery for glioblastoma multiforme","volume":"20","author":"Crowley","year":"2006"},{"key":"b25-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1515","article-title":"Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas","volume":"60","author":"DiBiase","year":"2004"},{"key":"b26-0270008","series-title":"Radiology","first-page":"823","article-title":"Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy","volume":"166","author":"Earnest","year":"1988"},{"key":"b27-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"879","article-title":"An integrated logistic formula for prediction of complications from radiosurgery","volume":"17","author":"Flickinger","year":"1989"},{"key":"b28-0270008","series-title":"J Clin Oncol","first-page":"5294","article-title":"Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study","volume":"23","author":"Galanis","year":"2005"},{"key":"b29-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"977","article-title":"Permanent 125iodine implants for recurrent malignant gliomas","volume":"43","author":"Gaspar","year":"1999"},{"key":"b30-0270008","series-title":"J Clin Oncol","first-page":"1642","article-title":"Stereotactic radiosurgery for recurrent malignant gliomas","volume":"13","author":"Hall","year":"1995"},{"key":"b31-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"541","article-title":"Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas","volume":"35","author":"Halligan","year":"1996"},{"key":"b32-0270008","series-title":"Neurology","first-page":"907","article-title":"Assumptions in the radiotherapy of glioblastoma","volume":"30","author":"Hochberg","year":"1980"},{"key":"b33-0270008","series-title":"Neurosurgery","first-page":"684","article-title":"Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme","volume":"57","author":"Hsieh","year":"2005"},{"key":"b34-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"293","article-title":"A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma","volume":"43","author":"Hudes","year":"1999"},{"key":"b35-0270008","series-title":"Clin Oncol (R Coll Radiol)","first-page":"581","article-title":"Diffusion tensor imaging: possible implications for radiotherapy treatment planning of patients with high-grade glioma","volume":"17","author":"Jena","year":"2005"},{"key":"b36-0270008","series-title":"Neurosurgery","first-page":"776","article-title":"Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms","volume":"41","author":"Kondziolka","year":"1997"},{"key":"b37-0270008","series-title":"J Neurosurg","first-page":"44","article-title":"Long-term outcomes after meningioma radiosurgery: physician and patient perspectives","volume":"91","author":"Kondziolka","year":"1999"},{"key":"b38-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1553","article-title":"Evidence that MR diffusion tensor imaging (tractography) predicts the natural history of regional progression in patients irradiated conformally for primary brain tumors","volume":"71","author":"Krishnan","year":"2008"},{"key":"b39-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1005","article-title":"Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma","volume":"41","author":"Laperriere","year":"1998"},{"key":"b40-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1045","article-title":"Gamma knife for glioma: selection factors and survival","volume":"36","author":"Larson","year":"1996"},{"key":"b41-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1397","article-title":"Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma","volume":"54","author":"Larson","year":"2002"},{"key":"b42-0270008","series-title":"Neuro-oncol","first-page":"119","article-title":"Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme","volume":"6","author":"Larson","year":"2004"},{"key":"b43-0270008","series-title":"Stereotact Funct Neurosurg","first-page":"162","article-title":"Recurrent glioblastoma multiforme: potential benefits using fractionated stereotactic radiotherapy and concurrent taxol","volume":"69","author":"Lederman","year":"1997"},{"key":"b44-0270008","series-title":"Am J Clin Oncol","first-page":"155","article-title":"Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel","volume":"23","author":"Lederman","year":"2000"},{"key":"b45-0270008","series-title":"Med Phys","first-page":"1563","article-title":"Functional magnetic resonance imaging aided radiation treatment planning","volume":"27","author":"Liu","year":"2000"},{"key":"b46-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1113","article-title":"The effect of setup uncertainties on the radiobiological advantage of fractionation in stereotaxic radiotherapy","volume":"34","author":"Lo","year":"1996"},{"key":"b47-0270008","series-title":"J Neurosurg","first-page":"210","article-title":"Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme","volume":"103","author":"Mahajan","year":"2005"},{"key":"b48-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"243","article-title":"Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume","volume":"7","author":"Marks","year":"1981"},{"key":"b49-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1350","article-title":"Reirradiation tolerance of the human brain","volume":"70","author":"Mayer","year":"2008"},{"key":"b50-0270008","series-title":"J Clin Oncol","first-page":"2529","article-title":"Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases","volume":"21","author":"Mehta","year":"2003"},{"key":"b51-0270008","series-title":"J Clin Oncol","first-page":"2563","article-title":"Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981\/22981-NCIC CE3 phase III randomized trial","volume":"24","author":"Mirimanoff","year":"2006"},{"key":"b52-0270008","series-title":"Br J Radiol","first-page":"347","article-title":"Use of MR spectroscopy and functional imaging in the treatment planning of gliomas","volume":"80","author":"Narayana","year":"2007"},{"key":"b53-0270008","series-title":"J Neurooncol","first-page":"185","article-title":"Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival","volume":"92","author":"Patel","year":"2009"},{"key":"b54-0270008","series-title":"Neurosurgery","first-page":"1123","article-title":"Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme","volume":"46","author":"Patel","year":"2000"},{"key":"b55-0270008","series-title":"J Neurooncol","first-page":"409","article-title":"Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma","volume":"4","author":"Pouratian","year":"2009"},{"key":"b56-0270008","series-title":"J Clin Oncol","first-page":"579","article-title":"Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma","volume":"27","author":"Prados","year":"2009"},{"key":"b57-0270008","series-title":"Eur J Cancer","first-page":"1809","article-title":"Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy","volume":"30A","author":"Rajan","year":"1994"},{"key":"b58-0270008","series-title":"Neuro-oncol","first-page":"330","article-title":"Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma","volume":"10","author":"Reardon","year":"2008"},{"key":"b59-0270008","series-title":"Technol Cancer Res Treat","first-page":"421","article-title":"Image-guided radiosurgical ablation of intra- and extra-cranial lesions","volume":"5","author":"Romanelli","year":"2006"},{"key":"b60-0270008","series-title":"Comput Aided Surg","first-page":"161","article-title":"Computer aided robotic radiosurgery","volume":"11","author":"Romanelli","year":"2006"},{"key":"b61-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"993","article-title":"A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas","volume":"70","author":"Schwer","year":"2008"},{"key":"b62-0270008","series-title":"Neurosurgery","first-page":"343","article-title":"The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine","volume":"51","author":"Selker","year":"2002"},{"key":"b63-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"291","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000"},{"key":"b64-0270008","series-title":"J Neurosurg","first-page":"972","article-title":"Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation","volume":"108","author":"Sheehan","year":"2008"},{"key":"b65-0270008","series-title":"J Neurosurg","first-page":"226","article-title":"Effect of trans sodium crocetinate on brain tumor oxgenation. Laboratory investigation","volume":"111","author":"Sheehan","year":"2009"},{"key":"b66-0270008","series-title":"J Neurosurg","first-page":"72","article-title":"Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome","volume":"90","author":"Shrieve","year":"1999"},{"key":"b67-0270008","series-title":"Neurosurgery","first-page":"275","article-title":"Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme","volume":"36","author":"Shrieve","year":"1995"},{"key":"b68-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"719","article-title":"Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost","volume":"29","author":"Sneed","year":"1994"},{"key":"b69-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"37","article-title":"Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme","volume":"35","author":"Sneed","year":"1996"},{"key":"b70-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"287","article-title":"Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +\/\u2212 hyperthermia for glioblastoma multiforme","volume":"40","author":"Sneed","year":"1998"},{"key":"b71-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"853","article-title":"Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol","volume":"60","author":"Souhami","year":"2004"},{"key":"b72-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"591","article-title":"Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas: a comparative survival analysis","volume":"30","author":"Stea","year":"1994"},{"key":"b73-0270008","series-title":"J Clin Oncol","first-page":"1375","article-title":"Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide","volume":"20","author":"Stupp","year":"2002"},{"key":"b74-0270008","series-title":"Lancet Oncol","first-page":"552","article-title":"Current and future developments in the use of temozolomide for the treatment of brain tumours","volume":"2","author":"Stupp","year":"2001"},{"key":"b75-0270008","series-title":"Lancet Oncol","first-page":"459","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009"},{"key":"b76-0270008","series-title":"N Engl J Med","first-page":"987","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005"},{"issue":"4 Suppl 13","key":"b77-0270008","series-title":"Semin Oncol","first-page":"19","article-title":"New approaches for temozolomide therapy: use in newly diagnosed glioma","volume":"28","author":"Stupp","year":"2001"},{"key":"b78-0270008","series-title":"Curr Neurol Neurosci Rep","first-page":"198","article-title":"Optimal role of temozolomide in the treatment of malignant gliomas","volume":"5","author":"Stupp","year":"2005"},{"key":"b79-0270008","series-title":"J Neurosurg","first-page":"297","article-title":"An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial","volume":"99","author":"Tatter","year":"2003"},{"key":"b80-0270008","series-title":"Neurosurg Rev","first-page":"417","article-title":"Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience","volume":"32","author":"Villavicencio","year":"2009"},{"key":"b81-0270008","series-title":"BMC Cancer","first-page":"55","article-title":"Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma","volume":"5","author":"Vordermark","year":"2005"},{"key":"b82-0270008","series-title":"Clin Cancer Res","first-page":"1253","article-title":"Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma","volume":"13","author":"Vredenburgh","year":"2007"},{"key":"b83-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1725","article-title":"An analysis of dose-effect relationship in the radiotherapy of malignant gliomas","volume":"5","author":"Walker","year":"1979"},{"key":"b84-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1405","article-title":"Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma","volume":"16","author":"Wallner","year":"1989"},{"key":"b85-0270008","series-title":"Cancer","first-page":"3029","article-title":"Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas","volume":"73","author":"Wen","year":"1994"},{"issue":"4 Suppl","key":"b86-0270008","series-title":"Int J Radiat Oncol Biol Phys","first-page":"S26","article-title":"Hypofractionated stereotactic radiotherapy combined with topotecan in recurrent malignant glioma","volume":"66","author":"Wurm","year":"2006"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/27\/6\/article-pE8.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/27\/6\/article-pE8.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/27\/6\/article-pE8.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:24:49Z","timestamp":1780129489000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/27\/6\/article-pE8.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":172,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2009.9.focus09187","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}